{
    "company_name": "FIREBRICK PHARMA LIMITED",
    "address": "Level 10, 440 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000",
    "summary": "Pharmaceutical development and manufacturing",
    "details": "Pharmaceutical development and manufacturing",
    "website": "https://www.firebrickpharma.com/",
    "stock_code": "FRE",
    "links": "['#fl-main-content', 'https://firebrickpharma.com', 'https://firebrickpharma.com/', 'https://firebrickpharma.com/about/', 'https://firebrickpharma.com/about/#homeabout', 'https://firebrickpharma.com/about/#history', 'https://firebrickpharma.com/about/#value', 'https://firebrickpharma.com/about/#ourteam', 'https://firebrickpharma.com/news/', 'https://firebrickpharma.com/investors/', 'https://firebrickpharma.com/contact/', 'https://firebrickpharma.com/about/', 'https://firebrickpharma.com/privacy-policy/', 'https://firebrickpharma.com/terms-conditions/', 'https://firebrickpharma.com/social-media-and-website-usage-policy/', 'https://www.facebook.com/firebrickpharma/', 'https://twitter.com/FirebrickPharma', 'https://www.linkedin.com/company/firebrick-pharma/', 'tel:1300301874', 'https://firebrickpharma.com', 'https://firebrickpharma.com/', 'https://firebrickpharma.com/about/', 'https://firebrickpharma.com/about/#homeabout', 'https://firebrickpharma.com/about/#history', 'https://firebrickpharma.com/about/#value', 'https://firebrickpharma.com/about/#ourteam', 'https://firebrickpharma.com/news/', 'https://firebrickpharma.com/investors/', 'https://firebrickpharma.com/contact/']",
    "images": "https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/30084156/Firebrick-Logo-1.svg, https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/26073156/home-banner-new.jpg",
    "company_logo_link": "https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/30084156/Firebrick-Logo-1.svg"
}